T-Cell Vaccine Reduces Simian Immunodeficiency Virus Levels In Semen Of Monkeys During Primary Infection
Sunday, October 25, 2009 - 20:21
in Health & Medicine
A new study reports that a vaccine-induced cellular immune response reduced simian immunodeficiency virus (SIV) levels in the semen of rhesus monkeys during the period of primary infection, a discovery that may ultimately aid in the fight against HIV-1 transmission in humans.
Read the whole article on Science Daily
More from Science Daily
Related
- Tips from the journals of the American Society for MicrobiologyFri, 23 Oct 2009, 14:16:23 EDT
- Novel vaccine approach offers hope in fight against HIVSun, 17 May 2009, 13:30:19 EDT
- Blocking immune inhibitor improves response to HIV-like virus, prolongs survival in monkeysWed, 10 Dec 2008, 13:49:54 EST
- Why some primates, but not humans, can live with immunodeficiency viruses and not progress to AIDSTue, 16 Sep 2008, 11:35:51 EDT
- Simian foamy virus found in several people living and working with monkeys in AsiaThu, 31 Jul 2008, 15:50:26 EDT